Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-10-31 Option Award | 2022-11-02 7:09 pm | N/A 2032-10-30 | Eliem Therapeutics Inc. | ELYM | Azelby Robert President & CEO | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 5:13 pm | N/A 2032-01-26 | Eliem Therapeutics Inc. | ELYM | Azelby Robert President & CEO | 500,000 | $0 | 500,000 (Direct) | View |
Ownership | 2021-08-09 6:02 pm | N/A 2031-02-25 | Eliem Therapeutics Inc. | ELYM | Azelby Robert Chief Executive Officer | 0 | $0 | 1,190,462 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-11 9:07 pm | N/A 2031-06-10 | Clovis Oncology Inc. | CLVS | Azelby Robert Director | 42,223 | $0 | 42,223 (Direct) | View |
| 2020-10-23 Disposition | 2020-10-23 5:34 pm | N/A N/A | IMMUNOMEDICS INC | IMMU | Azelby Robert Director | 32,758 | $0 | 0 (Direct) | View |
| 2020-06-18 Option Award | 2020-06-22 5:19 pm | 2021-06-18 2030-06-18 | IMMUNOMEDICS INC | IMMU | Azelby Robert Director | 10,258 | $0 | 10,258 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-05 4:55 pm | N/A 2030-06-04 | Clovis Oncology Inc. | CLVS | Azelby Robert Director | 40,138 | $0 | 40,138 (Direct) | View |
| 2020-02-26 Option Award | 2020-02-27 4:48 pm | 2021-02-26 2027-02-26 | IMMUNOMEDICS INC | IMMU | Azelby Robert Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2019-10-22 Disposition | 2019-10-24 6:52 pm | N/A 2028-06-12 | ALDER BIOPHARMACEUTICALS INC | ALDR | Azelby Robert President and CEO | 1,670,000 | $0 | 0 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-07 4:46 pm | N/A 2029-06-06 | Clovis Oncology Inc. | CLVS | Azelby Robert Director | 28,882 | $0 | 28,882 (Direct) | View |
| 2019-04-23 Option Award | 2019-04-25 6:56 pm | 2019-04-23 2028-06-12 | ALDER BIOPHARMACEUTICALS INC | ALDR | Azelby Robert President and CEO | 150,000 | $0 | 150,000 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 4:40 pm | N/A 2029-02-05 | ALDER BIOPHARMACEUTICALS INC | ALDR | Azelby Robert President and CEO | 520,000 | $0 | 520,000 (Direct) | View |
| 2018-10-11 Option Award | 2018-10-15 6:44 pm | N/A 2028-10-11 | Clovis Oncology Inc. | CLVS | Azelby Robert Director | 25,848 | $0 | 25,848 (Direct) | View |
| 2018-06-13 Option Award | 2018-06-15 4:02 pm | N/A 2028-06-12 | ALDER BIOPHARMACEUTICALS INC | ALDR | Azelby Robert President and CEO | 1,000,000 | $0 | 1,000,000 (Direct) | View |
Ownership | 2018-06-15 4:00 pm | N/A N/A | ALDER BIOPHARMACEUTICALS INC | ALDR | Azelby Robert President and CEO | 0 | $0 | 0 (Direct) | View |